Porcine PD-L1: cloning, characterization, and implications during xenotransplantation

被引:24
|
作者
Jeon, Dae-Hyun
Oh, Keunhee
Oh, Byoung C.
Nam, Dong H.
Kim, Chi H.
Park, Hyung-Bae
Cho, Jaejin
Lee, Jeong R.
Lee, Dong-Sup
Lee, Gene
机构
[1] Seoul Natl Univ, Lab Mol Genet & Stem Cell Differentiat, Seoul 110799, South Korea
[2] Seoul Natl Univ, Canc Res Inst, Lab Immunol, Seoul 110799, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
关键词
cell proliferation; human PD-1; human T cells; porcine PD-L1; xenotransplantation;
D O I
10.1111/j.1399-3089.2007.00403.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Effective intervention achieved by manipulating cell-mediated xenogeneic immune responses would critically increase the clinical feasibility of xenotransplantation as immediate hyperacute rejections become controllable through genetic modulations of donor organs. Endogenous negative regulatory signals like the programmed death 1 (PD-1)-programmed death ligand 1 (PD-L1) system are candidate targets for the control of cell-mediated xenogeneic immune response. Methods: A porcine PD-L1 molecule was cloned using RACE (rapid amplification of cDNA ends) technology based on the human PD-L1 sequence. The functional effects of cloned porcine PD-L1 were tested on human CD4(+) T cell activation using porcine PD-L1-transfected bystander cells. Cellular proliferation was monitored by [H-3] thymidine incorporation, and human T cell apoptosis was measured by flow cytometry. Results: Porcine PD-L1 (GenBank accession number AY837780) was found to have 73.8% sequence homology with human PD-L1 and to contain two immunoglobulin domains in its extracellular region. Moreover, porcine PD-L1 expressed on Chinese hamster ovary (CHO) cells inhibited human CD4(+) T cell proliferation stimulated with anti-CD3 only or anti-CD3 plus anti-CD28. Percentages of apoptotic activated human T cells increased by over 30% in the presence of porcine PD-L1/CHO cells, and the addition of recombinant human PD-1-Fc fusion proteins during human T cell activation reversed the inhibitory effects of porcine PD-L1. Conclusions: Cloned porcine PD-L1 showed high sequence homology with human PD-L1 and a similar molecular structure. Moreover, porcine PD-L1 inhibited human CD4(+) T cell activation in human PD-1-dependent manner, and this involved activated T cell apoptosis. The authors suggest that PD-1-PD-L1 might play an important endogenous immune regulatory role during xenogeneic transplantation, and that the effective application of this system would improve transplanted xenogeneic organ survival.
引用
收藏
页码:236 / 242
页数:7
相关论文
共 50 条
  • [21] Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade
    Lin, Heng
    Wei, Shuang
    Vatan, Linda
    Kryczek, Ilona
    Zou, Weiping
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [22] IFN-γ upregulates membranous and soluble PD-L1 in mesothelioma cells: potential implications for the clinical response to PD-1/PD-L1 blockade
    Maria Pia Pistillo
    Roberta Carosio
    Barbara Banelli
    Anna Morabito
    Luca Mastracci
    Paola Ferro
    Serena Varesano
    Roberta Venè
    Alessandro Poggi
    Silvio Roncella
    Cellular & Molecular Immunology, 2020, 17 : 410 - 411
  • [23] PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials
    Madore, Jason
    Vilain, Ricardo E.
    Menzies, Alexander M.
    Kakavand, Hojabr
    Wilmott, James S.
    Hyman, Jessica
    Yearley, Jennifer H.
    Kefford, Richard F.
    Thompson, John F.
    Long, Georgina V.
    Hersey, Peter
    Scolyer, Richard A.
    PIGMENT CELL & MELANOMA RESEARCH, 2015, 28 (03) : 245 - 253
  • [24] Comparison of PD-L1 Immunohistochemistry Assays and Response to PD-L1 Inhibitors
    Dacic, S.
    Ancevski, K.
    Aberrbock, S.
    Herbst, C.
    Villaruz, L.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2115 - S2115
  • [25] Relevance of host and tumor PD-L1 in PD-L1 pathway blockade
    Kryczek, Ilona
    Lin, Heng
    Wei, Shuang
    Green, Michael
    Zou, Weiping
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [26] PD-L1 blockade efficacy relies on host cell PD-L1
    Brownell, I.
    Udey, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : 1000 - 1000
  • [27] An alternatively spliced PD-L1 isoform PD-L1∆3, and PD-L2 expression in breast cancers: implications for eligibility scoring and immunotherapy response
    Didem Naz Dioken
    Ibrahim Ozgul
    Irem Yilmazbilek
    Mustafa Cengiz Yakicier
    Ezgi Karaca
    Ayse Elif Erson-Bensan
    Cancer Immunology, Immunotherapy, 2023, 72 : 4065 - 4075
  • [28] An alternatively spliced PD-L1 isoform PD-L1Δ3, and PD-L2 expression in breast cancers: implications for eligibility scoring and immunotherapy response
    Dioken, Didem Naz
    Ozgul, Ibrahim
    Yilmazbilek, Irem
    Yakicier, Mustafa Cengiz
    Karaca, Ezgi
    Erson-Bensan, Ayse Elif
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023,
  • [29] An alternatively spliced PD-L1 isoform PD-L1△3, and PD-L2 expression in breast cancers: implications for eligibility scoring and immunotherapy response
    Dioken, Didem Naz
    Ozgul, Ibrahim
    Yilmazbilek, Irem
    Yakicier, Mustafa Cengiz
    Karaca, Ezgi
    Erson-Bensan, Ayse Elif
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (12) : 4065 - 4075
  • [30] Determination of PD-L1 positive CETCs as a biomarker for PD-1/PD-L1 treatment monitoring
    Pizon, M.
    Schott, D.
    Pachmann, U.
    Pachmann, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 89 - 89